Connect with us

Media OutReach

2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies

Published

on

HANOI, VIETNAM – Media OutReach Neswire – 14 April 2025 – Together with world-renowned scientists including Prof. Joel F. Habener, Prof. Jens Juul Holst and Assoc. Prof. Svetlana Mojsov, Prof. Daniel Drucker at the University of Toronto and the Lunenfeld-Tanenbaum Research Institute, has discovered the role of glucagon-like peptide-1 (GLP-1), leading to life-changing therapies for people with diabetes and obesity while stimulating emerging applications for neurodegenerative diseases. This groundbreaking innovation has garnered significant recognition for him and the GLP-1 research group, exemplified by the prestigious 2023 VinFuture Special Prize for Innovators with Outstanding Achievements in Emerging Fields, and the 2025 Breakthrough Prize in Life Sciences, awarded earlier this April.

Prof. Daniel Drucker, 2023 VinFuture Special Prize Laureate for Innovators with Outstanding Achievements in Emerging Fields, continues to receive recognition with the 2025 Breakthrough Prize in Life Sciences

In this interview, he reflects on the impact and influences of the VinFuture Prize on his further research, as well as the challenges and prospects of expanding GLP-1 accessibility. As global scientific recognition continues to evolve, he shares insights into the vital role of initiatives like the VinFuture Prize in inspiring the next generation of scientists.

VinFuture: Recognizing transformative science

The 2023 VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and honor the scientists behind the discovery of the role of GLP-1. Following the VinFuture Prize, the GLP-1 research group has continuously received recognitions with numerous other prestigious accolades, including their listing among the 2024 Time 100 Most Influential People.

Reflecting on this, Prof. Drucker expressed deep appreciation, noting that these awards provide invaluable support in pushing the boundaries of scientific discovery.

As the VinFuture Prize gains prominence, having GLP-1 science acknowledged as a recipient also helps elevate the global understanding of how it can transform healthcare,” he emphasized.

Continuing its commitment to recognizing impactful advancements, the 2024 VinFuture Prize honored innovators in the biomedical field for their development of CAR T-cell therapy for cancer and other diseases. According to Prof. Drucker, this innovation stands as “a remarkable example of how immunological science can revolutionize the treatment of many cancer types.”

With the honoring of AI and CAR T cell therapy, the trends I observe are consistent with other international awards, where similar innovative themes are celebrated around the same time or within a few years. This alignment reinforces the importance of these breakthroughs.” Prof. Drucker commented.

Among the youngest international science-technology awards, now in its fifth year, the VinFuture Prize is steadily establishing its significance and reputation, evidenced by the increasing number of laureates continuing to receive recognition from prestigious international awards, most notably the Nobel Prize. Prominent examples include Dr. Katalin Karikó and Prof. Drew Weissman (Laureates of the 2021 VinFuture Grand Prize and 2023 Nobel Prize in Physiology or Medicine), Dr. Demis Hassabis and Dr. John Jumper (Laureates of the 2022 VinFuture Special Prize and 2024 Nobel Prize in Chemistry), and Prof. Geoffrey Hinton (Laureate of the 2024 VinFuture Grand Prize and 2024 Nobel Prize in Physics).

Despite being a relatively new award, the VinFuture Prize has done an exceptional job of highlighting high-quality science. The recognition of AI, coinciding with its recent recognition by the Nobel Prize, highlights its transformative impact on numerous aspects of society,” Prof. Drucker said. “So I think the VinFuture Prize council really has its finger on the leading edge of science in many areas.”

Beyond diabetes

2024 was a landmark year for GLP-1 research, with several exciting clinical trials demonstrating benefits extending far beyond obesity to include the treatment of patients with heart disease, obstructive sleep apnea, and knee osteoarthritis. Additionally, Prof. Drucker hinted at early promising results for patients with metabolic liver disease and noted ongoing studies exploring GLP-1’s effects on Alzheimer’s disease, with results expected soon.

The continuous wave of new findings will provide deeper insights into the full potential of GLP-1-based therapies.” Prof. Drucker commented, stating that each study will contribute to refining our understanding of this science.

Furthermore, Prof. Drucker highlighted GLP-1’s neurological effects and its potential clinical application in addressing mental health conditions, including anxiety, depression, and compulsive behaviors. He noted that preliminary, early-stage trials with small patient groups investigating GLP-1’s potential in reducing cravings and treating addiction-related disorders have yielded promising initial results.

Several academic research centers are actively studying GLP-1’s effects on substance use disorders, and major pharmaceutical companies such as Eli Lilly and Novo Nordisk have begun clinical trials to explore these applications further.” Prof. Drucker shared, “It will likely take 12 to 18 months before we gain a clearer picture of whether these medicines can be clinically effective in helping individuals reduce or quit substance use.”

Prof. Drucker also highlighted compelling research indicating GLP-1’s interaction with the brain, extends beyond appetite regulation, suggesting a range of potential therapeutic applications.

Ongoing trials are underway in people with substance use disorders, including alcohol, nicotine, cannabinoids, and opioids, conditions for which existing medicines are not always very effective.” He elaborated, “We have trials underway for Alzheimer’s disease with oral semaglutide, which are expected to conclude by the end of 2025. These investigations will significantly enhance our understanding of GLP-1’s neurological impact and potential clinical applications.

Overcome barriers to maximize impact

Despite the global excitement for the “Ozempic era”, there are many challenges hindering the widespread impact for GLP-1 medicines. These include the current high cost and limited accessibility of the treatments, the reliance on primarily two main drug options (semaglutide and tirzepatide), and the practical limitations of refrigeration and pen-based delivery for most formulations, as Prof. Drucker pointed out.

A key priority is the democratization of these treatments so that everyone who could benefit from them has access. To achieve this, we are working on small-molecule pills that are easier to manufacture and should be more affordable.” He explained.

Prof. Drucker anticipated that increased competition in the GLP-1 market will lead to lower prices, development of newer versions that are easier to use, including once-monthly injections, thereby improving accessibility and convenience for millions worldwide.

Most initial launches have occurred in countries with well-established healthcare and reimbursement systems. Only now are we seeing manufacturing capacity expand enough to increase availability, but costs remain a significant barrier.” He stated, emphasizing the critical need to advance these medicines not only to enhance their efficacy in areas like weight loss and cardiovascular health but also to make them more convenient to take, more affordable, and more broadly accessible to patients globally.

Another major challenge that Prof. Drucker identified is determining the appropriate dosage for extending the therapeutic applications of GLP-1 to conditions beyond diabetes and obesity. While the dosage effective for weight loss may not be suitable for other disorders like Parkinson’s, Alzheimer’s, alcohol use disorder, anxiety, or depression, understanding the dose-response relationship for these conditions requires time and further investigation.

Additionally, research is underway to reduce adverse effects, making GLP-1 treatments safer and more comfortable for patients. Prof. Drucker elaborated, “One key strategy is starting patients on very low doses and gradually increasing them to minimize side effects. Additionally, some companies are researching ways to reduce further adverse effects, such as developing co-formulated anti-nausea compounds to improve tolerability.”

Future research for GLP-1 therapies presents numerous possibilities; however, the translation from research to clinical application for neurodegenerative and substance use disorder treatments still presents unmet needs with a lack of evidence for progress. According to Prof. Drucker, with clinical trials underway, they may yield valuable insights within the next 12 to 24 months regarding the potential extension of GLP-1 therapy benefits from glucose control to complex disorders of the central nervous system.

He identified, “The key lies in understanding how to effectively engage the brain, identifying which regions can respond to GLP-1 signaling, and how to optimize that communication.”

In conclusion, Prof. Drucker highlighted the promising contemporary landscape of scientific research, emphasizing the crucial need to inspire the next generation to embrace science and pursue research careers. In this context, the 2023 VinFuture Special Prize Laureate commended the VinFuture Prize for its valuable contribution in motivating individuals within the scientific community and engaging younger generations in science.

When we visited Vietnam, we met with many young scientists, and I was impressed by VinFuture’s strong efforts to inspire and connect with them. I encourage VinFuture to continue and expand these efforts because investing in young talent is the key to a future filled with groundbreaking innovations.” He stated.

Hashtag: #VinFuture

The issuer is solely responsible for the content of this announcement.

VinFuture

The VinFuture Foundation, established on International Human Solidarity Day on December 20th, 2020, is a non-profit organization co-founded by billionaire Mr. Pham Nhat Vuong and his wife, Mrs. Pham Thu Huong. The Foundation’s core activity is awarding the annual VinFuture Prize, which recognizes transformative scientific and technological innovations capable of making significant positive changes in the lives of millions of people worldwide.

The nomination period for the 2025 VinFuture Prize will close at 2:00 PM on April 17, 2025 (Vietnam time, GMT+7). Submit your nominations here: . Outstanding nominators will be honored through the VinFuture Nominator Recognition Program.The VinFuture Prize consists of four prestigious awards presented each year. The most esteemed is the VinFuture Grand Prize, valued at US$3 million, making it one of the largest annual prizes globally. Additionally, there are three Special Prizes, each valued at US$500,000, specifically dedicated to honoring Women Innovators, Innovators from Developing Countries, and Innovators with Outstanding Achievements in Emerging Fields.

Media OutReach

No Judgement, No Awkwardness: More Hongkongers Are Opening Up to AI for Mental Health Support

Published

on

HONG KONG SAR – Media OutReach Newswire – 24 April 2026 – There is a particular kind of exhaustion that comes not from the stress itself, but from carrying it in silence — unsure whether it is serious enough to mention, or whether anyone would truly understand.

A newly completed Hong Kong study suggests there may finally be a way to bridge that gap. The AIM Greater China Psychology Research Group has completed a Hong Kong-based study conducted in the 2025–2026 academic year, comparing the effectiveness of human hypnotherapists against AI in delivering hypnotic experience-based stress relief experiences. The findings were striking: a significant proportion of participants felt that both approaches yielded virtually equivalent levels of relaxation — and more than 60% reported preferring their AI session after the fact.

Over 400 Applicants: A Reflection of a Generation in Need of Being Heard

The research team recruited participants experiencing family-related stress via Facebook. Within a short period of the post going live, over 400 individuals voluntarily applied — a figure that speaks not only to the pervasiveness of stress in modern life, but also to a growing willingness among the public to prioritise their own emotional wellbeing and actively seek self-care solutions.

From the applicant pool, 48 participants were randomly selected to take part. Each participant underwent two separate hypnotic experience stress relief audio sessions, each lasting approximately one hour — one recorded by a human hypnotherapist, and one fully generated by AI, including both the script and voice. Participants then compared their personal experiences of both sessions.

What Humans Can Do, AI Can Do Too

In the most critical area of comparison — stress relief effectiveness — the largest single group of participants (41.7%) rated the AI and human sessions as equally effective. On a scoring basis, the AI hypnotic experience averaged approximately 2.92 points, compared to 2.58 points for the human session — with AI coming out marginally ahead.

The study further found that nearly 90% of participants indicated they would enjoy a session if it genuinely helped them feel relaxed. In other words, what people truly care about is whether it works — not whether the voice behind it belongs to a human or a machine. On this front, AI has passed the test.

Over 60% More Willing to Share Their Feelings with AI

The results around personal preference were perhaps the most eye-opening. When asked which session they enjoyed more, 62.5% of participants chose the AI experience — and among women, that number climbed even higher, to 68.4%.

So what made AI the preferred choice? Researchers believe it comes down to one simple thing: feeling safe. With AI, there is no worry about being judged. No fear of saying the wrong thing. No awkwardness. About 1 in 4 participants said they actually found it easier to talk openly with AI — because it communicates in a way that feels clear, calm, and natural, much like everyday conversation.

The truth is, some things are just easier to say when no one is watching. That is not a flaw in human nature — it is simply how many of us work.

When it came to privacy, the findings were equally reassuring. More than half of all participants said they had no concerns about AI handling their personal information. Only a very small number — just 2.08% — said they felt uncomfortable. This points to a growing sense of trust in AI tools among the general public.

AI Reads the Data; Therapists Read the Person

Beyond the hypnotic experience itself, the local research team also evaluated AI’s capability as an analytical tool — with equally impressive results.

AI was able to rapidly process large volumes of participant responses, objectively assess individual stress levels, and identify underlying patterns. For instance, AI identified that 35% of participants independently expressed a desire for “personal space” or “better soundproofing” in their homes. On the surface, these may seem like trivial lifestyle concerns — yet AI connected this pattern to the reality of Hong Kong residents living in constrained spaces, highlighting a deeper psychological sense of having “nowhere to breathe”. This level of insight would be difficult to uncover through manual review of dozens of questionnaires alone.

AI also observed that many participants habitually occupied the role of “problem-solver” or “mediator” within their households, suppressing their own emotional needs in the process. Researchers noted that this reflects a widely recognised social phenomenon — the pressures faced by eldest daughters and the so-called “sandwich generation,” caught between the responsibilities of caring for ageing parents and raising children. AI’s ability to rapidly identify these hidden emotional burdens allows therapists to bypass lengthy preliminary assessments and focus more swiftly on the core issues that require their attention.

AI Is Here to Help, Not to Take Over

The local research team emphasises that the study was never intended to position AI as a replacement for human therapists. Rather, the aim is to explore how the two can work in tandem. Much like how blood test reports assist physicians in diagnosis, AI can play an analogous supporting role in the mental health field — organising data, identifying patterns, and lowering barriers to seeking help, so that mental health professionals can direct their energy towards the moments that truly require a human touch.

Those who proactively seek psychological support remain a minority, often deterred by the fear of inconvenience, social stigma, or the awkwardness of speaking up. If AI can serve as the bridge that encourages more people to take that first step, that alone may be its most meaningful contribution to society.

Hashtag: #HypnosisInstitute

The issuer is solely responsible for the content of this announcement.

About Hypnosis Institute

Hypnosis Institute is dedicated to helping people in Hong Kong lead healthier and more fulfilling lives through hypnotic experience. We offer accessible and practical hypnotic experience training programmes designed to integrate hypnotic techniques into everyday life, with a focus on stress management, emotional wellbeing, and personal growth.

Hypnosis Institute is Hong Kong’s only hypnotic experience professional development platform that simultaneously operates a research group, social innovation group, practical training group, crisis psychological support group, charitable initiatives, networking events, therapeutic services, and a comprehensive training pathway.

As the sole Hong Kong chapter of the Association for Integrative Medicine (AIM) in the United States, the sole overseas Hong Kong academy of UK educational institution Study House (Quality Licence Scheme), and the sole specialist hypnotic experience training school in Hong Kong under Cambridge International College in the United Kingdom, Hypnosis Institute provides internationally recognised qualifications that contribute to the advancement of the industry.

Founder Charles Leung is a trainer of trainers in the field of hypnotic experience, and has been specially appointed by the Association for Integrative Medicine as the Chief Instructor for Specialist hypnotic experience in Greater China. He has trained over 1,000 hypnotherapists and instructors, upholding the highest standards of professional development in the mental health field.

The Institute’s programmes integrate a comprehensive range of methodologies, including hypnotic experience combined with MBTI personality profiling, DISC behavioural analysis, mental health coaching, emotional education, and the HiddenMe Cards inner child tool — providing a holistic and personalised approach to hypnotic experience practice. Instructors specialise in paediatric hypnotic experience, Internal Family Systems (including inner child) hypnotic experience, stress and insomnia relief hypnotic experience, interpersonal relationship hypnotic experience, as well as hypnotic experience in reminiscence and palliative care.

Driven by the belief that everyone can harness the power of hypnotic experience to enhance their mental wellbeing, Hypnosis Institute is committed to sharing psychological knowledge and providing professional support in the areas of emotional management, life challenges, and the professional development of the hypnotic experience industry.

Follow us at , , and for the latest updates.

Continue Reading

Media OutReach

Reimagining Capital: Inside BizPal Day 2026 and the Launch of CapitalOS

Published

on

JOHOR, MALAYSIA – Media OutReach Newswire – 24 April 2026 – BizPal Malaysia hosted BizPal Day 2026, an invite-only event bringing together investors, SME founders, and ecosystem partners in Johor, where the company formally introduced CapitalOS, its corporate finance platform, and signed Memoranda of Understanding (MOUs) with Malaysian partners My Education Platform and VA Partners.

Attendees of BizPal Day 2026 gather in Johor, Malaysia, bringing together investors, SME founders, and ecosystem partners for the official introduction of CapitalOS, BizPal’s corporate finance platform.

Held at deMori @ FCC Signature, the event featured a live platform demonstration, partner showcase, and networking sessions aimed at facilitating engagement between founders, advisors, and investors.

Introducing CapitalOS

CapitalOS, BizPal’s corporate finance platform, was presented through a live demonstration during the event. The system integrates operational, brand, and financial data into a structured framework designed to support investor readiness and due diligence.

According to BizPal, the platform is intended to help SMEs organise their business information into formats aligned with investor expectations, enabling clearer communication during fundraising discussions.

“SMEs should never walk into a funding conversation unsure of their numbers,” said Ms. Anya Tan, CEO of BizPal Malaysia.

MOUs Expand Distribution Network

The event also included the signing of Memoranda of Understanding between BizPal and two Malaysian partners, My Education Platform and VA Partners. Both organisations will serve as authorised distributors of BizPal’s education and advisory programmes across Malaysia.

Representatives from BizPal and My Education Platform formalise their collaboration through a Memorandum of Understanding (MOU), expanding BizPal’s distribution network across Malaysia.
Representatives from BizPal and My Education Platform formalise their collaboration through a Memorandum of Understanding (MOU), expanding BizPal’s distribution network across Malaysia.

The partnerships expand BizPal’s reach within the SME ecosystem by working with local organisations that support business development and capability building.

“Partnering with BizPal allows us to introduce structured, investor-ready methodologies to the SME community we serve,” said Mr. Jeff Lee, Director, My Education Platform.

A representative from VA Partners is expected to provide a statement following final endorsement.

Global Mentorship Exchange (GMX)

During the event, BizPal also presented the Global Mentorship Exchange (GMX), an ecosystem initiative designed to connect experienced business leaders with high-potential entrepreneurs.

The initiative provides a structured environment for mentorship supported by data-based evaluation and standardised assessment criteria aligned with investor expectations. GMX was first introduced during BizPal’s Data Fundraising Masterclass in December 2025 and was presented to a broader network of partners and investors at BizPal Day.

Next Steps

Following the event, BizPal plans to expand the adoption of CapitalOS and continue developing its partner network across Malaysia and the ASEAN region.
Hashtag: #NoDataNoTalk #DataFundraising #InvestorReady #CapitalReadiness #FinTech #BusinessValuation #ASEANSMEs #BizPalDay


The issuer is solely responsible for the content of this announcement.

About BizPal

BizPal provides data-driven corporate finance solutions designed to help ASEAN SMEs become investor-ready. Its platform, CapitalOS, integrates operational, strategic, and financial data into a unified system that supports business evaluation and investor engagement.

Continue Reading

Media OutReach

Vinhomes Green Paradise Can Gio And IHG Hotels & Resorts Partner To Bring Four International Hotel Brands To The Coastal Mega Urban Development

Published

on

HANOI, VIETNAM – Media OutReach Newswire – 23 April 2026 – Cangio Tourist City Corporation, the developer of Vinhomes Green Paradise, and IHG Hotels & Resorts, one of the world’s leading hotel companies, have signed a strategic partnership agreement to introduce IHG’s hotel brands to Vinhomes Green Paradise Can Gio in Ho Chi Minh City. The collaboration will not only enhance the project’s service ecosystem to international standards, but also lay the foundation for a leading coastal mega urban development, reinforcing Vinhomes Green Paradise Can Gio’s position on the global tourism and resort map.

Under the agreement, IHG will develop four hotels with a total of more than 1,000 rooms at Vinhomes Green Paradise Can Gio, including InterContinental Saigon Can Gio with 400 rooms, Crowne Plaza Saigon Can Gio with 400 rooms, Holiday Inn Express Saigon Can Gio with 130 rooms, and Garner Saigon Can Gio with 130 rooms.

InterContinental Saigon Can Gio, a world-renowned luxury brand, will deliver premium hospitality experiences tailored to international travelers and domestic guests seeking high-end accommodation. Crowne Plaza Saigon Can Gio, one of the largest upscale hotel brands globally, will cater to frequent travelers with modern, flexible spaces designed to optimize productivity and foster connections.

Holiday Inn Express Saigon Can Gio and Garner Saigon Can Gio will expand the destination’s accommodation offering with efficient, high-quality stays focused on value, making the development more accessible to a broader range of guests. This also marks the official debut of both brands in the Vietnamese market.

According to the development timeline, Holiday Inn Express Saigon Can Gio and Garner Saigon Can Gio are expected to open in 2028, followed by InterContinental Saigon Can Gio and Crowne Plaza Saigon Can Gio in 2030.

In this partnership, Vinpearl, a member of Vingroup, will act as the project operator and lead the collaboration with IHG Hotels & Resorts, while coordinating with all stakeholders throughout the development and operational phases.

Together with Vinpearl’s world-class hospitality brand, the addition of four premium IHG hotels will help realize a 7,000-room accommodation ecosystem at Vinhomes Green Paradise Can Gio, meeting the growing demand for extended stays and diverse experiences year-round in Can Gio and Ho Chi Minh City.

Complementing the hospitality offering, a series of large-scale entertainment and resort facilities unique to Vinhomes Green Paradise Can Gio will further elevate the destination. These include the 122-hectare VinWonders theme park featuring the world’s tallest artificial snow mountain and nearly 200 attractions, the 5,000-seat Blue Waves Theater, the 800-hectare Paradise Lagoon, the five-star international cruise port Landmark Harbour, and two 18-hole international-standard golf courses. Together, these developments aim to position Can Gio as a globally-recognized tourism and resort hub, targeting 40 million visitors annually and standing alongside leading destinations in Vietnam and worldwide.

Mr. Rajit Sukumaran, Senior Vice President and Managing Director, East Asia & Pacific, IHG Hotels & Resorts, said: “This agreement marks the beginning of a strategic partnership between IHG and Vingroup. Bringing four of our standout brands to Vinhomes Green Paradise Can Gio reflects the diversity of our portfolio, as well as our strong commitment to supporting Vietnam’s goal of becoming a leading global tourism destination. With brands spanning multiple segments, we believe this collaboration will help create an integrated hospitality ecosystem that meets the diverse needs of travelers at one of Vietnam’s most significant developments.”

Ms. Ngo Thi Huong, Chief Executive Officer of Vinpearl Joint Stock Company, said: “We selected IHG not only for its global brand portfolio but also for its proven operational expertise across international markets. Introducing InterContinental, Crowne Plaza, Holiday Inn Express, and Garner to Vinhomes Green Paradise Can Gio is a key step in completing our service structure and establishing international operating standards for the mega project’s hotel system. With this partnership as a foundation, we believe Vinhomes Green Paradise will progressively emerge as a world-class destination, where a fully integrated ecosystem continues to enhance its appeal to residents and both domestic and international visitors.”

Vinhomes Green Paradise is located in the southeastern part of Ho Chi Minh City. Construction began on April 19, 2025, with a total area of 2,870 hectares. The development features three sides facing the sea and is adjacent to the Can Gio Mangrove Biosphere Reserve, a UNESCO-recognized site. The project is being developed to leading ESG++ standards, integrating green, smart, ecological, and regenerative principles.

The development benefits from a well-connected transport infrastructure network, including the Ben Thanh – Can Gio high-speed railway, which will reduce travel time from central Ho Chi Minh City to just 13 minutes, the Can Gio Bridge, the interchange connecting Rung Sac Road with the Ben Luc – Long Thanh Expressway, and the Can Gio – Vung Tau sea-crossing route, enabling travel between two major tourism hubs in just 10 minutes.

With a diverse range of accommodation options, internationally-standardized hotel systems, and a wide array of cultural, artistic, sports, and entertainment facilities aligned with green, smart, and community-friendly principles, Vinhomes Green Paradise Can Gio stands out as a rare mega urban development that both sets new benchmarks for ESG living and delivers a world-class tourism and resort experience.

Hashtag: #Vinhomes

The issuer is solely responsible for the content of this announcement.

About IHG Hotels & Resorts:

IHG Hotels & Resorts is a global hospitality company with a portfolio of 21 brands and IHG One Rewards, one of the world’s largest hotel loyalty programs with over 160 million members. IHG currently franchises, leases, manages, or owns more than 6,900 hotels across over 100 countries, with more than 2,300 hotels in its development pipeline.

IHG’s brand portfolio spans Luxury & Lifestyle, Premium, Essentials, and Suites segments, including well-known brands such as Six Senses, Regent, InterContinental, Crowne Plaza, Holiday Inn Express, Garner, Staybridge Suites, and Candlewood Suites.

About Vinhomes
Vinhomes is Vietnam’s leading real estate developer, pioneering the development of large-scale, well-planned urban areas with integrated amenities, green living environments, and modern lifestyles. In addition to 36 urban developments currently in operation nationwide, Vinhomes continues to focus on building next-generation mega and super urban developments of regional scale and significance, aspiring to create some of the most livable cities in the world while significantly transforming Vietnam’s urban landscape.

For more information, please visit

Continue Reading

Trending